1 |
Stevens Smith H, Russell HV, Lee BH, Morain SR; and the Value of Exome Sequencing Delphi Panel. Using the Delphi method to identify clinicians’ perceived importance of pediatric exome sequencing results. Genet Med 2020;22:69-76. [DOI: 10.1038/s41436-019-0601-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
2 |
Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, Massingham LJ, Miller D, Yu TW, Hisama FM; ACMG Board of Directors. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021. [PMID: 34211152 DOI: 10.1038/s41436-021-01242-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
3 |
Smith HS, Brothers KB, Knight SJ, Ackerman SL, Rini C, Veenstra DL, McGuire AL, Wilfond BS, Malek J. Conceptualization of utility in translational clinical genomics research. Am J Hum Genet 2021;108:2027-36. [PMID: 34687653 DOI: 10.1016/j.ajhg.2021.08.013] [Reference Citation Analysis]
|
4 |
Malinowski J, Miller DT, Demmer L, Gannon J, Pereira EM, Schroeder MC, Scheuner MT, Tsai AC, Hickey SE, Shen J; ACMG Professional Practice and Guidelines Committee. Systematic evidence-based review: outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability. Genet Med 2020;22:986-1004. [PMID: 32203227 DOI: 10.1038/s41436-020-0771-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
|
5 |
Hayeems RZ, Luca S, Assamad D, Bhatt A, Ungar WJ. Utility of Genetic Testing from the Perspective of Parents/Caregivers: A Scoping Review. Children (Basel) 2021;8:259. [PMID: 33801725 DOI: 10.3390/children8040259] [Reference Citation Analysis]
|